Barnes & Noble Inc | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (2)

Latest Articles

About This Stock More About This Stock
Bull Of The Day: Barnes & Noble
Article By: Tracey Ryniec
Thursday, October 9, 2014 5:53 PM EDT
Barnes & Noble, Inc. was left for dead by investors a few years ago on fears that the retail-store book business was collapsing.
In this article: BKS
Read
Will Hibbett's Initiatives Keep Growth Momentum Alive?
Article By: Zacks Investment Research
Tuesday, September 30, 2014 3:00 PM EDT
Sporting goods retailer Hibbett Sports Inc. (HIBB - Analyst Report), managed to post better-than-expected bottom-line results for second-quarter fiscal 2015 despite reduced margins due to higher markdowns and increased input as well as operating costs.
In this article: BKS, DKS, SPCHA, HIBB, ULTA
Read
Will Bed Bath & Beyond (BBBY) Earnings Disappoint In Q2?
Article By: Zacks Investment Research
Monday, September 22, 2014 7:15 PM EDT
Why we're both encouraged and apprehensive about Tuesday's earnings report.
In this article: BKS, CMG, BBBY, BJRI
Read
Short Watch List
Article By: Blair Jensen
Wednesday, September 10, 2014 11:43 AM EDT
With the market breaking below near term support it’s time to look at short candidates.
In this article: APC, BKS, CVX, HLF, MCD, MOS, RSH, FNSR, FOSL, TZA
Read
Can Google Save Barnes & Noble From Amazon.com?
Article By: Leigh Drogen
Monday, September 8, 2014 10:53 PM EDT
Barnes and Noble has been struggling with its bottom line as Amazon has stepped up its book sales efforts. To fight back against Amazon, BNS has joined forces with Google to revitalize its online sales. But BNS made one mistake in the partnership...
In this article: BKS, AMZN, GOOG
Read
Barchart Morning Call 5/19
Article By: Jim Van Meerten
Monday, May 19, 2014 10:46 AM EDT
June E-mini S&Ps (ESM14 -0.19%) this morning are down -0.36% and European stocks are down -0.75%. AstraZeneca is down 13% in pre-market trading and is leading health-care stocks lower after it rejected Pfizer's upward revised $117 billion bid for the company as too low.
In this article: ABT, ATK, AZN, BKS, CPB, DB, DDD, ED, GNW, GS, HPQ, HTZ, KMI, T, VAL, BRCM, CSCO, DTV, FOSL, MU, ORCL, SIRI, URBN
Read

Latest Tweets for $BKS

No tweets yet!

PARTNER HEADLINES